The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.

Trump selected McCrery Architects to lead the design for the 90,000 square foot ballroom, according to a media release from the administration. The Washington-based architecture firm is owned by James McCrery, a practitioner of classical and traditional architecture and a professor at the Catholic University of America in Washington, D.C.

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some limitations.

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.

Donald Trump has outed White House communications chief and resident attack dog Steven Cheung as a user of “fat drugs.” Announcing plans to slim down the cost of popular weight loss drugs, the president began naming his cabinet members and aides, asking if they needed such medication.

Cornell University said it reached an agreement with the White House to restore about $250 million in federal funding, becoming the latest elite school to negotiate relief in response to the Trump administration’s campaign to remake higher education.

The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday during an event, according to sources familiar with the situation, pushing shares of the two companies higher as investors bet on increased patient access in government health programs.

White House press secretary Karoline Leavitt shares what it has been like balancing her job and being a mother on ‘My View.’